BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26406331)

  • 1. Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients.
    Nielsen MJ; Kazankov K; Leeming DJ; Karsdal MA; Krag A; Barrera F; McLeod D; George J; Grønbæk H
    PLoS One; 2015; 10(9):e0137302. PubMed ID: 26406331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury.
    Nielsen MJ; Karsdal MA; Kazankov K; Grønbaek H; Krag A; Leeming DJ; Schuppan D; George J
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1242-1252. PubMed ID: 27696451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of liver fibrosis progression and regression by a serological collagen turnover profile.
    Karsdal MA; Hjuler ST; Luo Y; Rasmussen DGK; Nielsen MJ; Holm Nielsen S; Leeming DJ; Goodman Z; Arch RH; Patel K; Schuppan D
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G25-G31. PubMed ID: 30160980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered balance between collagen formation and degradation after successful direct-acting antiviral therapy of chronic hepatitis C.
    Laursen TL; Villesen IF; Leeming DJ; Karsdal MA; Sølund C; Tarp B; Kristensen LH; Holmboe CH; Leutscher P; Laursen AL; Gudmann NS; Grønbaek H
    J Viral Hepat; 2021 Feb; 28(2):236-244. PubMed ID: 33058390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome.
    Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
    J Hepatol; 2014 Jul; 61(1):22-7. PubMed ID: 24607623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C.
    Nielsen MJ; Veidal SS; Karsdal MA; Ørsnes-Leeming DJ; Vainer B; Gardner SD; Hamatake R; Goodman ZD; Schuppan D; Patel K
    Liver Int; 2015 Feb; 35(2):429-37. PubMed ID: 25308921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis--a serological evaluation.
    Leeming DJ; Byrjalsen I; Jiménez W; Christiansen C; Karsdal MA
    Liver Int; 2013 Mar; 33(3):439-47. PubMed ID: 23279004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
    Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O
    RMD Open; 2024 May; 10(2):. PubMed ID: 38806188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.
    Shaker OG; Senousy MA
    J Viral Hepat; 2017 Aug; 24(8):636-644. PubMed ID: 28211229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C.
    Cheung KJ; Tilleman K; Deforce D; Colle I; Moreno C; Gustot T; Van Vlierberghe H
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):701-10. PubMed ID: 21623191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study.
    Juhl P; Bay-Jensen AC; Karsdal M; Siebuhr AS; Franchimont N; Chavez J
    PLoS One; 2018; 13(12):e0207324. PubMed ID: 30507931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers.
    Leeming DJ; Anadol E; Schierwagen R; Karsdal MA; Byrjalsen I; Nielsen MJ; Schwarzer-Zander C; Boesecke C; Bendtsen F; Møller S; Strassburg CP; Spengler U; Krag A; Rockstroh J; Trebicka JK
    AIDS; 2014 Sep; 28(14):2081-90. PubMed ID: 25136933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy.
    Nielsen SH; Mygind ND; Michelsen MM; Bechsgaard DF; Suhrs HE; Genovese F; Nielsen HB; Brix S; Karsdal M; Prescott E; Kastrup J
    Eur J Prev Cardiol; 2018 May; 25(7):719-727. PubMed ID: 29436257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus.
    Lubner MG; Jones D; Kloke J; Said A; Pickhardt PJ
    Br J Radiol; 2019 Jan; 92(1093):20180153. PubMed ID: 30182750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.
    Christensen TD; Jensen C; Larsen O; Leerhøy B; Hansen CP; Madsen K; Høgdall D; Karsdal MA; Chen IM; Nielsen D; Johansen JS; Willumsen N
    Int J Cancer; 2023 Mar; 152(5):1036-1049. PubMed ID: 36455598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis.
    Attallah AM; Albannan MS; Omran MM; Zayed R; Saif S; Farid A; Hassany M; Yosry A; Omran D
    Br J Biomed Sci; 2019 Jul; 76(3):105-110. PubMed ID: 30924403
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension.
    Leeming DJ; Karsdal MA; Byrjalsen I; Bendtsen F; Trebicka J; Nielsen MJ; Christiansen C; Møller S; Krag A
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1086-96. PubMed ID: 24099470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART.
    Dold L; Nielsen MJ; Praktiknjo M; Schwarze-Zander C; Boesecke C; Schierwagen R; Mohr R; Wasmuth JC; Jansen C; Bischoff J; Rockstroh JK; Karsdal MA; Spengler U; Trebicka J; Leeming DJ
    PLoS One; 2019; 14(7):e0219526. PubMed ID: 31295293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study.
    Ferraioli G; Tinelli C; Dal Bello B; Zicchetti M; Filice G; Filice C;
    Hepatology; 2012 Dec; 56(6):2125-33. PubMed ID: 22767302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.